Studying heart healing after TAVI with FAPI-PET scan
Part of Heart & circulation clinical trials.
This study uses a special type of PET scan (FAPI-PET) to see how the heart heals after a less invasive valve replacement procedure called TAVI. It aims to help doctors better understand the changes in heart tissue after treatment for aortic stenosis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have severe aortic stenosis (a narrowed heart valve) confirmed by a heart ultrasound.
- A heart team must have decided that TAVI (a less-invasive valve replacement) is the best option for you, or you chose not to have TAVI.
- You should not have had a heart attack, active heart inflammation, or heart infection in the last month.
- You should not have other serious heart conditions like severe mitral valve problems or uncontrolled dangerous heart rhythms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial uses a PET scan to study how local inflammation inside the heart affects the heart’s electrical wiring after a minimally invasive aortic valve procedure. The results may help doctors better predict or prevent rhythm and conduction problems after treatment.
This study looks at whether certain valve blood clots (called “subclinical leaflet thrombosis”) and different valve types are linked to valve aging over time. It uses a special PET-CT scan and an echocardiogram to measure changes in the heart valve about five years after TAVI.
This study looks at how well the new heart valve works after a TAVI procedure, using pressure measurements to see if blood flow improves. It aims to confirm that the treatment is effective for people with severe aortic stenosis.
This study looks at people with severe aortic stenosis who are getting a TAVI procedure (a way to replace the heart valve without open surgery) to see if we can predict how well they will do afterwards. It may help doctors plan better care and rehab for people like you.
This study is looking at how well doctors can reach the coronary arteries (the blood vessels that supply the heart muscle) after a TAVI procedure using the Evolut FX Plus valve. It may help improve future procedures for people with severe aortic stenosis.
This trial studies whether a new through-the-blood-vessel heart valve (TAVR) is safe and works well for people with severe aortic stenosis who are too risky for traditional surgery. If you qualify, you would be closely followed to check your symptoms and valve function over time.
Hear when a new Severe Aortic Valve Stenosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.